Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Document Type
- Journal article (10)
Language
- English (10)
Keywords
- colorectal cancer (2)
- 1st-line treatment (1)
- 5-Fluorouracil (1)
- Beta-catenin (1)
- CD62L (1)
- Carcinoma cells (1)
- DNA damage (1)
- DNA repair (1)
- Fibroblasts (1)
- Fluorouracil (1)
- Immunosenescence (1)
- Invasion (1)
- Krebs <Medizin> (1)
- MAPK pathway (1)
- MAPK signaling cascades (1)
- Matrix (1)
- Multicenter randomized-trial (1)
- PDGF (1)
- PI3K/Akt/mTOR (1)
- Regulatory T cells (1)
- T cell receptors (1)
- T cells (1)
- TCR signaling cascade (1)
- TLR2 (1)
- TLR4 (1)
- TLR9 (1)
- TREC (1)
- Telomere (1)
- Tissue (1)
- V. saphena magna (1)
- alternative splicing (1)
- caco-2 cells (1)
- carcinogenesis (1)
- carcinomas (1)
- cell cycle and cell division (1)
- colon (1)
- colon carcinoma cells (1)
- gastric cancer (1)
- gene regulation (1)
- glucose metabolism (1)
- human cancer (1)
- inflammation (1)
- inguinal lymph node dissection (1)
- malignant melanoma (1)
- measles virus (1)
- metachronous (1)
- metastasis (1)
- pancreatic cancer (1)
- perioperative chemotherapy (1)
- peripheral blood lymphocytes (1)
- peritoneal carcinomatosis (1)
- protein expression (1)
- radiosensitivity (1)
- recurrence survival (1)
- regional recurrence (1)
- reverse transcriptase-polymerase chain reaction (1)
- risk factors (1)
- small interferring RNA (1)
- tumor growth (1)
Institute
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (9)
- Comprehensive Cancer Center Mainfranken (1)
- Kinderklinik und Poliklinik (1)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Klinik und Poliklinik für Strahlentherapie (1)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (1)
- Medizinische Klinik und Poliklinik I (1)
- Pathologisches Institut (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
The cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncogenic factor that stabilises the c-Myc protein. CIP2A is overexpressed in several tumours, and expression levels are an independent marker for long-term outcome. To determine whether CIP2A expression is elevated in colon cancer and whether it might serve as a prognostic marker for survival, we analysed CIP2A mRNA expression by real-time PCR in 104 colon cancer samples. CIP2A mRNA was overexpressed in colon cancer samples and CIP2A expression levels correlated significantly with tumour stage. We found that CIP2A serves as an independent prognostic marker for disease-free and overall survival. Further, we investigated CIP2A-dependent effects on levels of c-Myc, Akt and on cell proliferation in three colon cancer cell lines by silencing CIP2A using small interfering (si) and short hairpin (sh) RNAs. Depletion of CIP2A substantially inhibited growth of colon cell lines and reduced c-Myc levels without affecting expression or function of the upstream regulatory kinase, Akt. Expression of CIP2A was found to be dependent on MAPK activity, linking elevated c-Myc expression to deregulated signal transduction in colon cancer.